selectively vulnerable hippocampus following transient forebrain
ischemia in gerbils. Exp Neurol 135:17–27.
Han SH, Hulette C, Saunders AM, Einstein G, Pericak-Vance M,
Strittmatter WJ, Roses AD, Schmechel DE. 1994a. Apolipoprotein
E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp Neurol 128:13–26.
Han SH, Einstein G, Weisgraber KH, Strittmatter WJ, Saunders AM,
Pericak-Vance M, Roses AD, Schmechel DE. 1994b. Apolipoprotein
E is localized to the cytoplasm of human cortical neurons: a light
and electron microscopic study. J Neuropathol Exp Neurol 53:535–
544.
Horsburgh K, Graham DI, Stewart J, Nicoll JAR. 1999. Influence of
Apolipoprotein E genotype on neuronal damage and apoE immunoreactivity in human hippocampus following global ischemia. J Neuropathol Exp Neurol 58:227–234.
Kosik KS, Joachim CL, Selkoe DJ. 1986. Microtubule-associated protein tau is a major antigenic component of paired helical filaments
in Alzheimer disease. Proc Natl Acad. Sci. USA 83:4044 – 4048.
Laws SM, Taddei K, Martins G, Paton A, Fiser C, Clarnette R,
Hallmayer J, Brooks WS, Gandy SE, Martins RN. 1999. The
-491AA polymorphism in the APOE gene is associated with in- creased plasma apoE levels in Alzheimer's disease. NeuroReport
10:879 – 882
Mercken L, Brion JP. 1995. Phosphorylation of tau protein is not
affected in mice lacking apoliprotein E. NeuroReport 6:2381–2384.
Mercken M, Vandermeeren M, Lu ̈ bke U, Six J, Boons J, Van de
Voorde A, Martin JJ, Gheuens J. 1992. Monoclonal antibodies with
selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol (Berl) 84:265–272
Metzger RE, LaDu ML, Pan JB, Getz GS, Frail DE, Falduto MT. 1996.
Neurons of the human frontal cortex display apolipoprotein E
immunoreactivity: Implications for Alzheimer's disease. J Neuropathol Exp Neurol 55:372–380.
Mirra SS, Hyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM,
Vogel FS, Hughes JP, van Belle G, Berg L, participating CERAD
neuropathologists. 1991. The consortium to establish a registry for
Alzheimer's disease (CERAD). Part II Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479 –
486.
Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik CM. 1997.
Presence of the apolipoprotein E type e4 allele is not associated with
neurofibrillary pathology or biochemical changes to tau protein.
Dement Geriatr Cogn Disord 8:288 –295.
Nagy ZS, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith
AD. 1995. Influence of the apolipoprotein E genotype on amyloid
deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 69:757–761.
Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. 1991. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and
neurofibrillary tangles in Alzheimer's disease and kuru plaque
amyloid in Creutzfeldt-Jacob disease. Brain Res 541:163–166.
Ohm TG, Kirca M, Bohl J, Scharnagl J, Grob W. Ma ̈ rz W. 1995.
Apolipoprotein E polymorphism influences not only cerebral senile
plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 66:583–587.
Perry G, Cras P, Kawai M, Mulvihill P, Tabaton M. 1991. Transformation of neurofibrillary tangles in the extracellular space. Bull
Clin Neurosci 56:107–119.
Poirier J. 1994. Apolipoprotein E in animal models of CNS injury and
in Alzheimer's disease. Trends Neurosci 17:525–530.
Poirier J, Hess M, May PC, Finch CE. 1991. Astrocytic apolipoprotein
E mRNA and GFAP mRNA in hippocampus after enthorinal cortex
lesioning. Mol Brain Res 11:97–106.
Richey L, Siedlak SL, Smith MA, Perry G. 1995. Apolipoprotein E
interaction with the neurofibrillary tangles and senile plaques in
Alzheimer disease: implications for disease pathogenesis. Biochem
Biophys Res Commun 208:657– 663.
Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH,
Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, CrapperMacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D,
Roses AD. 1993. Association of apolipoprotein E allele e4 with
late-onset familial and sporadic Alzheimer's disease. Neurology 43:
1467–1472.
Snow AD, Mar H, Nochlin D, Sekiguchi RT, Kimata K, Koike Y, Wight
TN. 1990. Early accumulation of heparan sulfate in neurons and in
the beta-amyloid protein-containing lesions of Alzheimer's disease
and Down's syndrome. Am J Pathol 137:1253–1270.
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, En- ghild J, Salvensen GS, Roses AD. 1993. Apolipoprotein E highavidity binding to β amyloid and increase frequency of type 4 allele
